Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
CHU Montpellier, Montpellier, France.
J Gynecol Obstet Hum Reprod. 2021 May;50(5):101931. doi: 10.1016/j.jogoh.2020.101931. Epub 2020 Oct 3.
Outpatient procedure in cancer surgery is one of the tracks to guarantee the quality of care respecting the delay of support. The aim of this study was to assess the feasibility and safety of outpatients with axillary lymphadenectomy and the postoperative morbidity after outpatient's procedures compared to patients with classic hospitalization.
Patients who underwent axillary lymphadenectomy for breast cancer or melanoma were analyzed. We selected patients having axillary lymphadenectomy only or associated with another operative act compatible with outpatient's procedure (partial mastectomy, lumpectomy or skin excisions).
Three hundred and forty-nine patients were included. Outpatient procedures were performed in 142 patients (40.7%) and inpatient procedures were performed in 207 patients (59.3%). All time complications combined, we found 148 patients with at least one complication: 77 patients (52.0%) and 71 patients (48.0%) in outpatient and inpatient group, respectively (p=0.0002). The main complication was seroma formation, it concerned 104 patients Among them, Seroma formation was more frequent in ambulatory group, 60 patients (57.7%) and 44 patients (42.3%) in traditional hospitalization (p<0.0001) but 58.7% (61/104) needed only one aspiration and all complications were managed in outpatient.
Complications (mostly seroma) appeared usually after hospitalization discharge and they were known and simple to take in charge. A precise preoperative information concerning post-operative morbidity, specially seroma allows a better comprehension and acceptation of this side effect. We believe that this surgery is feasible and safe in outpatient procedure.
癌症手术中的门诊程序是保证在不延迟支持的情况下保证护理质量的途径之一。本研究的目的是评估腋窝淋巴结清扫术门诊患者的可行性和安全性,以及与经典住院患者相比,门诊手术后的发病率。
分析了接受腋窝淋巴结清扫术治疗乳腺癌或黑色素瘤的患者。我们选择仅接受腋窝淋巴结清扫术或与另一种符合门诊程序的手术(部分乳房切除术、肿块切除术或皮肤切除术)相关的患者。
共纳入 349 例患者。142 例患者(40.7%)接受门诊手术,207 例患者(59.3%)接受住院手术。所有并发的时间并发症,我们发现有 148 例患者至少有一个并发症:门诊组 77 例(52.0%)和住院组 71 例(48.0%)(p=0.0002)。主要并发症是血清肿形成,共 104 例,其中门诊组 60 例(57.7%),传统住院组 44 例(42.3%)(p<0.0001),但 58.7%(61/104)仅需一次抽吸,所有并发症均可在门诊处理。
并发症(主要是血清肿)通常在出院后出现,并且易于识别和处理。关于术后发病率,特别是血清肿,术前信息详细可以让患者更好地理解和接受这种副作用。我们认为这种手术在门诊手术中是可行和安全的。